Clear all search history
Law & Crime
Disasters & Accidents
War & Conflict
Hospitality & Recreation
Nexavar articles over last 30 days
articles last 30 days
articles per day
Mentioned in this news
India’s Narendra Modi pressed to address intellec...
... for Indian consumers. On the pharmaceutical front, more than a dozen drugs — such as
, used to treat kidney disease — have had their patents denied or revoked while Indian...
Read more at
The Washington Times
Doctors Without Borders
Access to good therapy is big issue for patients ...
Sutent had its patents overridden, and the authorities issued a “compulsory licence” on Bayer’s
, authorising generic producers to sell it at far lower cost in exchange for a small royalty...
Read more at Swissinfo
Intellectual property rights issues could get a r...
... to Natco Pharma to produce and sell generic versions of Bayer-Onyx’s cancer drug,
. Under its annual report on the trade practices of various countries – Special 301 – the US...
Read more at
Business Standard India
Huge strategies by pharma companies
... off the first compulsory licence from Bayer for its patent-protected anti-cancer drug
in a landmark judgment by India's patent office in March 2012. Besides, despite global...
Read more at Business Standard India
US Food and Drug Administration
JOINING THE BATTLE
... standard of care for hepatocellular carcinoma liver cancer. "Aside from the resection and the
that he initially took, there is no standard treatment for this type of cancer,” she said....
Read more at The Wilson Times
Latest from Twitter
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.